Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-10-29

Clinical Trial Update: The Use of Evicel to Reduce Blood Loss in Total Knee Replacement Surgery [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessed Evicel fibrin sealant for reducing blood loss during total knee replacement in patients with osteoarthritis; the study is comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Evicel

Snippet

Sponsor: Hospital for Special Surgery, New York | Conditions: Osteoarthritis | Phase 4 | Status: COMPLETED | Results posted: 2013-10-29